145 related articles for article (PubMed ID: 7514063)
21. Immunohistochemical localization of complement regulatory proteins in the human retina.
Fett AL; Hermann MM; Muether PS; Kirchhof B; Fauser S
Histol Histopathol; 2012 Mar; 27(3):357-64. PubMed ID: 22237713
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of complement regulatory proteins decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 during human spermatogenesis.
Simpson KL; Holmes CH
Immunology; 1994 Mar; 81(3):452-61. PubMed ID: 7515850
[TBL] [Abstract][Full Text] [Related]
23. Complement regulatory proteins and autoimmunity.
Kawano M
Arch Immunol Ther Exp (Warsz); 2000; 48(5):367-72. PubMed ID: 11140463
[TBL] [Abstract][Full Text] [Related]
24. Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1.
Hourcade D; Liszewski MK; Krych-Goldberg M; Atkinson JP
Immunopharmacology; 2000 Aug; 49(1-2):103-16. PubMed ID: 10904110
[TBL] [Abstract][Full Text] [Related]
25. Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation.
van Beek J; van Meurs M; 't Hart BA; Brok HP; Neal JW; Chatagner A; Harris CL; Omidvar N; Morgan BP; Laman JD; Gasque P
J Immunol; 2005 Feb; 174(4):2353-65. PubMed ID: 15699172
[TBL] [Abstract][Full Text] [Related]
26. An enzyme-linked immunosorbent assay for complement regulatory proteins and membrane-bound immunoglobulins on intact red blood cells.
Jones DR; Thompson RJ; Rao SA; Imrie H
J Immunol Methods; 1994 Dec; 177(1-2):235-42. PubMed ID: 7529808
[TBL] [Abstract][Full Text] [Related]
27. Complement-binding proteins are strongly expressed by human preimplantation blastocysts and cumulus cells as well as gametes.
Taylor CT; Johnson PM
Mol Hum Reprod; 1996 Jan; 2(1):52-9. PubMed ID: 9238658
[TBL] [Abstract][Full Text] [Related]
28. Development of an ELISA assay for soluble CD35 (C3b/C4b receptor): high levels of soluble CD35 in LE-positive patients with hematological malignancies.
Hara T; Fukuda H; Masaoka T; Matsumoto M; Seya T
Immunol Lett; 1994 Jul; 41(2-3):249-53. PubMed ID: 8002046
[TBL] [Abstract][Full Text] [Related]
29. [Effect of macrophage colony-stimulating factor on complement receptors and complement regulatory proteins on human peripheral white blood cells].
Nakahara R; Takemura S; Onodera H; Kasamatsu Y; Seto N; Ichio N; Doi T; Nakanishi S; Okamoto M; Yanagida K; Ueda M; Deguchi M; Kondo M
Arerugi; 1996 Dec; 45(12):1256-61. PubMed ID: 9133336
[TBL] [Abstract][Full Text] [Related]
30. Expression of complement regulating factors in gastric cancer cells.
Inoue T; Yamakawa M; Takahashi T
Mol Pathol; 2002 Jun; 55(3):193-9. PubMed ID: 12032231
[TBL] [Abstract][Full Text] [Related]
31. Expression of complement regulatory proteins on fetal blood cells in utero.
Jarvis JN; Moore HT; Fine N; Berry SM
Biol Neonate; 1996; 69(4):225-9. PubMed ID: 8724649
[TBL] [Abstract][Full Text] [Related]
32. Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.
Simpson KL; Jones A; Norman S; Holmes CH
Am J Pathol; 1997 Nov; 151(5):1455-67. PubMed ID: 9358772
[TBL] [Abstract][Full Text] [Related]
33. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM
Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
[TBL] [Abstract][Full Text] [Related]
34. The influence of complement receptor type 1 (CD35) and decay-accelerating factor (CD55) on complement receptor type 2- (CD21) mediated alternative pathway activation by B cells.
Leslie RG
Immunology; 1999 Jul; 97(3):371-3. PubMed ID: 10447756
[TBL] [Abstract][Full Text] [Related]
35. Complement receptor type 1 (CR1/CD35) expressed on activated human CD4+ T cells contributes to generation of regulatory T cells.
Török K; Dezső B; Bencsik A; Uzonyi B; Erdei A
Immunol Lett; 2015 Apr; 164(2):117-24. PubMed ID: 25742728
[TBL] [Abstract][Full Text] [Related]
36. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.
Matsumoto M; Sugita Y; Seya T
Eur J Immunol; 1991 Aug; 21(8):1787-92. PubMed ID: 1714391
[TBL] [Abstract][Full Text] [Related]
37. Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas.
Koretz K; Brüderlein S; Henne C; Möller P
Br J Cancer; 1992 Nov; 66(5):810-4. PubMed ID: 1384641
[TBL] [Abstract][Full Text] [Related]
38. Human CD46 rather than CD55 is a key element in protection against complement activation in vitro.
van Dixhoorn MG; Dekker S; Janssen RW; Verbakel CA; Grosveld F
Transplant Proc; 2000 Aug; 32(5):916-8. PubMed ID: 10936272
[No Abstract] [Full Text] [Related]
39. Complement regulatory proteins in early human fetal life: CD59, membrane co-factor protein (MCP) and decay-accelerating factor (DAF) are differentially expressed in the developing liver.
Simpson KL; Houlihan JM; Holmes CH
Immunology; 1993 Oct; 80(2):183-90. PubMed ID: 7505254
[TBL] [Abstract][Full Text] [Related]
40. Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF.
Li B; Sallee C; Dehoff M; Foley S; Molina H; Holers VM
J Immunol; 1993 Oct; 151(8):4295-305. PubMed ID: 7691944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
